From “what is this?”
to “what will it cost me?”
Understand it. Calculate the dose.
Build your plan.
Not sure where to start? Take the three-question quiz.
Popular right now
Retatrutide
Triple-receptor agonistAn investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, with published Phase 3 results.
Explore Retatrutide
MOTS-c
Your mitochondrial DNA encodes this peptide. Researchers are exploring its connection to exercise, energy metabolism, and aging.
Explore MOTS-c
BPC-157
Popular for its tendon and gut repair claims. But most of the supporting research comes from animal studies, not human trials.
Explore BPC-157
CJC-1295
DAC or no DAC? They're not interchangeable. The long-acting version has published human trials. The other has far less evidence.
Explore CJC-1295
Ipamorelin
A five-amino-acid peptide that stimulates your body's own growth hormone release. Its broader benefits in humans remain uncertain.
Explore IpamorelinCommonly compared
Similar names. Different science. See how the evidence compares.
CJC-1295With DAC vs Without DAC
Similar names. Different release profiles. See what DAC changes and what has actually been studied.
Read comparisonBPC-157 vs TB-500
Two repair-focused peptides that are constantly grouped together, but differ in structure, claims, and evidence.
Semaglutide vs Tirzepatide vs Retatrutide
How the leading GLP-1 and multi-agonist drugs differ in mechanism, evidence, and stage.
KLOW vs GLOW
A side-by-side look at what each blend contains and how the formulas actually differ.
Glutathione vs NAD+
Two popular wellness injectables with very different roles, claims, and research context.
See the studies behind the claims
Every compound in the library is placed by the furthest human trial on record, counted from ClinicalTrials.gov and Europe PMC. 133 of the 440 compounds indexed so far have no clinical trial on record.
Counted from Europe PMC and ClinicalTrials.gov indexing; a missing record does not prove no trial exists. Counted November 15, 2026.
New in research
Fresh research, new findings, and practical guides from Peptide Decoding.
Do Peptides Need to Be Stored in the Dark? What the Labels Actually Protect
What tesamorelin, semaglutide and tirzepatide labels protect from light, why packaging matters, and what has not been measured for research-use vials.
Is Semaglutide Not Working Because of Your Genes? For About 1 in 400
Semaglutide not working? In 1 in 400 people, rare GLP1R gene variants cut weight loss to 2.4% against 8.8%. Tirzepatide still worked. What the study found.
Does Retatrutide Help Knee Arthritis Pain? What the NEJM Trials Actually Show
Retatrutide and knee arthritis pain: two NEJM trials found 1.4 to 1.8 points more relief than placebo on a 0 to 10 scale, not the 75.8% in Lilly's release.
The math behind the vial.
Reconstitution calculations, vial longevity, and prices per milligram. Two tools that make the numbers easier to understand.
Know what the numbers mean.
Work out concentration, syringe units, cost per use, and how long a vial will last.
See what the listings actually cost.
Compare vial sizes, vendor listings, and price per milligram in one place.
